We are live on ! Find out more
MC

Moors & Cabot Portfolio holdings

AUM $2.34B
1-Year Est. Return 30.42%
This Fund
S&P 500
This Quarter Est. Return
-1.11%
1 Year Est. Return
+30.42%
3 Year Est. Return
+101.7%
5 Year Est. Return
+135.96%
10 Year Est. Return
+427.28%
AUM
$1.47B
AUM Growth
-$31.2M
Cap. Flow
+$9.51M
Cap. Flow %
0.64%
Top 10 Hldgs %
23.15%
Holding
894
New
55
Increased
342
Reduced
366
Closed
48

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$7.22M
2
OKE icon
Oneok
OKE
+$3.8M
3
MSFT icon
Microsoft
MSFT
+$3.42M
4
TSLA icon
Tesla
TSLA
+$3.35M
5
DE icon
Deere & Co
DE
+$3.28M

Top Sells

Rank Stock Value
1
MMP
Magellan Midstream Partners, L.P.
MMP
+$5.74M
2
NKE icon
Nike
NKE
+$4.85M
3
PFE icon
Pfizer
PFE
+$2.98M
4
ALL icon
Allstate
ALL
+$2.73M
5
NVDA icon
NVIDIA
NVDA
+$2.27M

Sector Composition

Rank Sector Weight
1 Technology 19.76%
2 Energy 13.29%
3 Healthcare 10.79%
4 Financials 10.18%
5 Industrials 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GE icon
101
GE Aerospace
GE
$367B
$3.27M 0.22%
37,031
-3,151
-8% -$283K
PNC icon
102
PNC Financial Services
PNC
$100B
$3.22M 0.22%
26,196
-2,115
-7% -$266K
SYK icon
103
Stryker
SYK
$127B
$3.21M 0.22%
11,748
-45
-0.4% -$12.9K
HAL icon
104
Halliburton
HAL
$27.9B
$3.18M 0.22%
78,447
-2,732
-3% -$107K
DOW icon
105
Dow Inc
DOW
$21.6B
$3.17M 0.21%
61,403
-3,387
-5% -$182K
INDB icon
106
Independent Bank
INDB
$4.05B
$3.11M 0.21%
63,441
+459
+0.7% +$24.4K
SYY icon
107
Sysco
SYY
$39.7B
$3.05M 0.21%
46,140
+3,914
+9% +$281K
CL icon
108
Colgate-Palmolive
CL
$72.6B
$3.01M 0.2%
42,309
-102
-0.2% -$7.63K
APD icon
109
Air Products & Chemicals
APD
$66.3B
$3M 0.2%
10,585
+618
+6% +$181K
T icon
110
AT&T
T
$165B
$2.99M 0.2%
199,185
-53,262
-21% -$781K
NVS icon
111
Novartis
NVS
$295B
$2.98M 0.2%
29,292
+250
+0.9% +$25.4K
SHEL icon
112
Shell
SHEL
$245B
$2.97M 0.2%
46,114
+6,884
+18% +$428K
MDLZ icon
113
Mondelez International
MDLZ
$77.7B
$2.97M 0.2%
42,754
+1,159
+3% +$83.5K
NTR icon
114
Nutrien
NTR
$32.7B
$2.92M 0.2%
47,331
+1,510
+3% +$95.5K
MRNA icon
115
Moderna
MRNA
$21.5B
$2.88M 0.2%
27,901
-7,007
-20% -$782K
ZTS icon
116
Zoetis
ZTS
$31.6B
$2.86M 0.19%
16,427
+149
+0.9% +$27.1K
IVV icon
117
iShares Core S&P 500 ETF
IVV
$876B
$2.76M 0.19%
6,430
+204
+3% +$91.2K
CSX icon
118
CSX Corp
CSX
$98.6B
$2.72M 0.18%
88,517
+750
+0.9% +$23.8K
STAG icon
119
STAG Industrial
STAG
$7.86B
$2.71M 0.18%
78,425
+1,295
+2% +$47K
TMO icon
120
Thermo Fisher Scientific
TMO
$211B
$2.7M 0.18%
5,334
+1,152
+28% +$614K
CI icon
121
Cigna
CI
$76.6B
$2.66M 0.18%
9,294
-92
-1% -$26.2K
WFC icon
122
Wells Fargo
WFC
$261B
$2.64M 0.18%
64,659
-1,781
-3% -$76.9K
FISV
123
Fiserv Inc
FISV
$27.2B
$2.64M 0.18%
23,360
-368
-2% -$45.3K
KMB icon
124
Kimberly-Clark
KMB
$36.4B
$2.63M 0.18%
21,776
+687
+3% +$88.7K
PARA
125
DELISTED
Paramount Global Class B
PARA
$2.61M 0.18%
202,251
+20,291
+11% +$301K

Similar funds

Moors & Cabot's Q3 2023 Portfolio in Review

As of Q3 2023, Moors & Cabot held 894 positions worth $1.47B, down 2.1% from $1.51B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Moors & Cabot's Q3 2023 filing shows 55 new, 342 increased, 366 reduced and 48 closed positions. Its largest new stake was Kenvue: 80,674 shares worth $1.62M. The largest sale was Magellan Midstream Partners, L.P., an estimated $5.74M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Energy and Healthcare.

  • Moors & Cabot's largest Q3 2023 buy was Kenvue: 80,674 shares worth $1.62M.
  • Moors & Cabot added most to Apple in Q3 2023, an estimated $7.22M increase.
  • Moors & Cabot's biggest Q3 2023 reduction was Nike, cutting an estimated $4.85M.
  • Moors & Cabot fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $5.74M.
  • Moors & Cabot's ten largest holdings make up 23% of its $1.47B portfolio in Q3 2023.
  • Moors & Cabot opened 55 new positions and closed 48 in Q3 2023.
  • Moors & Cabot's portfolio value fell 2.1% quarter-over-quarter to $1.47B.

Based on Moors & Cabot's 13F filing for Q3 2023, filed 8 Nov 2023.